Searching... Searching...
  • NVP + NA
  • Köp NA
  • Sälj NA
  • Senast NA
  • SEK

  • NEVPF +NA
  • Buy NA
  • Sell NA
  • Latest NA
  • USD

General meetings

Annual General Meeting (AGM)

The AGM, which is the company’s highest decision making body, is the forum where shareholders exercise their influence over the company. NeuroVive’s AGM is held yearly and is open to all shareholders.

At the AGM, shareholders are offered the opportunity to put questions directly to the Chair, Board of Directors and CEO, even if the company does endeavor to respond to questions from shareholders whenever they arise in the year. The AGM resolves on matters including adopting the Income Statement and Balance Sheet, appropriation of the company's profit or loss, discharging the Board members and Chief Executive Officer from liability, election of Board members, Chair, as well as election of auditors and approval of fees to the Board of Directors and auditors.

Documents

Annual General Meeting 2019

Annual General Meeting of NeuroVive Pharmaceutical AB (publ) was held on 25 April 2019 at 4 p.m. at Medicon Village, Scheelevägen 2, in Lund, Sweden. 

Extraordinary General Meeting 2019

Extraordinary General Meeting of NeuroVive was held at 1 pm on Thursday 17 January 2019 at Medicon Village, Scheelevägen 2, in Lund, Sweden.

Annual General Meeting 2018

Annual General Meeting for NeuroVive Pharmaceutical AB (publ) was held at 10:00 a.m. CEST on April 27, 2018, at Medicon Village, Scheelevägen 2, Lund, Sweden.

Extraordinary General Meeting 2018

Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ) was held at 2 p.m. CET on 22 March 2018 at Medicon Village, Scheelevägen 2, Lund, Sweden.

Annual General Meeting 2017

Annual General Meeting 2016

Extra General Meeting 2016

Annual General Meeting 2015

Comments are closed.

IR Contact

Catharina Johansson

CFO

ir@neurovive.com

+46 (0) 46-275 62 21